First Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Hold
8,635
0.17% 91
2026
Q1
$524K Hold
8,635
0.21% 80
2025
Q4
$466K Sell
8,635
-507
-6% -$24.4K 0.18% 87
2025
Q3
$412K Sell
9,142
-600
-6% -$28K 0.16% 93
2025
Q2
$451K Hold
9,742
0.2% 77
2025
Q1
$594K Sell
9,742
-11
-0.1% -$641 0.29% 70
2024
Q4
$552K Hold
9,753
0.26% 71
2024
Q3
$505K Hold
9,753
0.24% 77
2024
Q2
$405K Sell
9,753
-1,253
-11% -$56.1K 0.21% 85
2024
Q1
$597K Sell
11,006
-5,865
-35% -$299K 0.3% 70
2023
Q4
$866K Sell
16,871
-1
-0% -$52 0.44% 51
2023
Q3
$979K Buy
16,872
+5,810
+53% +$356K 0.57% 42
2023
Q2
$707K Sell
11,062
-22
-0.2% -$1.48K 0.45% 49
2023
Q1
$768K Hold
11,084
0.48% 46
2022
Q4
$797K Hold
11,084
0.49% 48
2022
Q3
$788K Buy
11,084
+44
+0.4% +$3.19K 0.53% 42
2022
Q2
$851K Sell
11,040
-400
-3% -$30.5K 0.56% 38
2022
Q1
$835K Sell
11,440
-100
-0.9% -$6.71K 0.51% 45
2021
Q4
$719K Buy
11,540
+53
+0.5% +$3.11K 0.44% 52
2021
Q3
$679K Buy
11,487
+100
+0.9% +$6.59K 0.45% 50
2021
Q2
$761K Buy
11,387
+447
+4% +$29.1K 0.51% 44
2021
Q1
$691K Sell
10,940
-300
-3% -$18.7K 0.48% 47
2020
Q4
$697K Hold
11,240
0.51% 47
2020
Q3
$677K Hold
11,240
0.57% 42
2020
Q2
$660K Sell
11,240
-350
-3% -$20.9K 0.56% 43
2020
Q1
$646K Buy
11,590
+140
+1% +$8.56K 0.59% 42
2019
Q4
$735K Sell
11,450
-276
-2% -$15.8K 0.53% 42
2019
Q3
$595K Buy
11,726
+26
+0.2% +$1.22K 0.46% 50
2019
Q2
$530K Sell
11,700
-700
-6% -$32.6K 0.43% 52
2019
Q1
$591K Buy
12,400
+300
+2% +$14.9K 0.44% 53
2018
Q4
$629K Sell
12,100
-100
-0.8% -$5.37K 0.51% 42
2018
Q3
$757K Sell
12,200
-200
-2% -$11.9K 0.5% 41
2018
Q2
$686K Hold
12,400
0.48% 42
2018
Q1
$784K Hold
12,400
0.56% 36
2017
Q4
$760K Sell
12,400
-150
-1% -$9.38K 0.49% 45
2017
Q3
$800K Buy
12,550
+1,000
+9% +$58.4K 0.52% 41
2017
Q2
$643K Hold
11,550
0.41% 55
2017
Q1
$628K Sell
11,550
-840
-7% -$46.1K 0.4% 55
2016
Q4
$724K Hold
12,390
0.43% 53
2016
Q3
$668K Hold
12,390
0.4% 54
2016
Q2
$911K Sell
12,390
-1,478
-11% -$104K 0.53% 42
2016
Q1
$886K Sell
13,868
-100
-0.7% -$6.31K 0.46% 56
2015
Q4
$961K Hold
13,968
0.51% 50
2015
Q3
$827K Hold
13,968
0.46% 58
2015
Q2
$930K Hold
13,968
0.47% 56
2015
Q1
$901K Hold
13,968
0.45% 56
2014
Q4
$824K Sell
13,968
-235
-2% -$13.3K 0.41% 61
2014
Q3
$727K Buy
14,203
+840
+6% +$42K 0.36% 66
2014
Q2
$648K Hold
13,363
0.31% 74
2014
Q1
$695K Buy
13,363
+478
+4% +$25.4K 0.33% 72
2013
Q4
$685K Sell
12,885
-200
-2% -$10.2K 0.32% 75
2013
Q3
$605K Sell
13,085
-804
-6% -$35.3K 0.3% 82
2013
Q2
$620K Buy
+13,889
New +$603K 0.31% 79

Other funds holding BMY

First Financial Corp's BMY Position: Q2 2026 in Review

First Financial Corp held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 8,635 shares worth $498K. The position accounts for 0.17% of the portfolio, ranked #91.

First Financial Corp first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $979K in Q3 2023. 903 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • First Financial Corp held 8,635 shares of Bristol-Myers Squibb worth $498K as of Q2 2026.
  • First Financial Corp left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.17% of First Financial Corp's portfolio in Q2 2026, its #91 holding.
  • First Financial Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • First Financial Corp's Bristol-Myers Squibb position peaked at $979K in Q3 2023.
  • 903 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.